"Antigen-Presenting Cells" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A heterogeneous group of immunocompetent cells that mediate the cellular immune response by processing and presenting antigens to the T-cells. Traditional antigen-presenting cells include MACROPHAGES; DENDRITIC CELLS; LANGERHANS CELLS; and B-LYMPHOCYTES. FOLLICULAR DENDRITIC CELLS are not traditional antigen-presenting cells, but because they hold antigen on their cell surface in the form of IMMUNE COMPLEXES for B-cell recognition they are considered so by some authors.
Descriptor ID |
D000938
|
MeSH Number(s) |
A11.066 A15.382.066
|
Concept/Terms |
Antigen-Presenting Cells- Antigen-Presenting Cells
- Antigen Presenting Cells
- Antigen-Presenting Cell
- Cell, Antigen-Presenting
- Cells, Antigen-Presenting
- Accessory Cells, Immunologic
- Immunologic Accessory Cells
- Cells, Immunologic Accessory
- Immunologic Accessory Cell
- Accessory Cell, Immunologic
- Cell, Immunologic Accessory
|
Below are MeSH descriptors whose meaning is more general than "Antigen-Presenting Cells".
Below are MeSH descriptors whose meaning is more specific than "Antigen-Presenting Cells".
This graph shows the total number of publications written about "Antigen-Presenting Cells" by people in this website by year, and whether "Antigen-Presenting Cells" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2004 | 0 | 1 | 1 |
2006 | 1 | 0 | 1 |
2007 | 1 | 0 | 1 |
2008 | 1 | 1 | 2 |
2009 | 3 | 0 | 3 |
2012 | 2 | 0 | 2 |
2013 | 1 | 0 | 1 |
2014 | 1 | 0 | 1 |
2017 | 2 | 8 | 10 |
2018 | 4 | 4 | 8 |
2019 | 0 | 3 | 3 |
2020 | 1 | 1 | 2 |
2021 | 0 | 3 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Antigen-Presenting Cells" by people in Profiles.
-
Targeting SARS-CoV-2 receptor-binding domain to cells expressing CD40 improves protection to infection in convalescent macaques. Nat Commun. 2021 09 01; 12(1):5215.
-
Intradermal immunization-a dose-sparing strategy to combat global shortages of severe acute respiratory syndrome coronavirus 2 vaccines? Clin Microbiol Infect. 2022 01; 28(1):6-8.
-
Brief report: Tempol, a novel antioxidant, inhibits both activated T cell and antigen presenting cell derived cytokines in-vitro from COVID-19 patients. Clin Immunol. 2021 10; 231:108828.
-
Intranasal vaccines for SARS-CoV-2: From challenges to potential in COVID-19 management. Drug Discov Today. 2021 11; 26(11):2619-2636.
-
Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity. Nat Commun. 2021 07 05; 12(1):4117.
-
COVID-19 Severity in Obesity: Leptin and Inflammatory Cytokine Interplay in the Link Between High Morbidity and Mortality. Front Immunol. 2021; 12:649359.
-
Homotaurine limits the spreading of T cell autoreactivity within the CNS and ameliorates disease in a model of multiple sclerosis. Sci Rep. 2021 03 08; 11(1):5402.
-
CERI, CEFX, and CPI: Largely Improved Positive Controls for Testing Antigen-Specific T Cell Function in PBMC Compared to CEF. Cells. 2021 01 27; 10(2).
-
Messenger RNA vaccines against SARS-CoV-2. Cell. 2021 03 18; 184(6):1401.
-
Bacillus Calmette-Guérin (BCG) vaccine generates immunoregulatory cells in the cervical lymph nodes in guinea pigs injected intra dermally. Vaccine. 2020 11 10; 38(48):7629-7637.